A Phase 2 Study of BMS-754807 Combined with Letrozole or BMS-754807 Alone in Hormone Receptor- Positive Breast Cancer Subjects with Acquired Resistance to Non-Steroidal Aromatase Inhibitors
|Effective start/end date||2/17/11 → 2/17/14|
- BRISTOL-MYERS SQUIBB PHARM RES
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.